Literature DB >> 10210738

The influence of water content and drug solubility on the formulation of pellets by extrusion and spheronisation.

C Lustig-Gustafsson1, H Kaur Johal, F Podczeck, J M Newton.   

Abstract

The influence of drug solubility in the range 14.3-1000 gl-1 on the formation of pellets by extrusion and spheronisation has been investigated by evaluating the performance of a series of model drugs mixed with an equal part by weight of microcrystalline cellulose. The optimum formulation in terms of pellet roundness and the maximum quantity within a limited size range was established by preparing samples with a range of water levels. The range of water levels over which pellets could be formed was found to be dependent on the model drug and its particle size. In general the force necessary to extrude the wet mass through the ram extruder was found to decrease as the quantity of water added increased. The optimum water level required to form the best quality pellets was found to decrease as a linear function of the natural logarithm of the water solubility of the drug. If allowance is made for the loss of solid by dissolution of the drug, there is an increase in the apparent water content necessary to form good spheres above a critical solubility between 350 and 400 gl-1.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210738     DOI: 10.1016/s0928-0987(99)00004-4

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Quantification of mass transfer during spheronisation.

Authors:  Martin Koester; Markus Thommes
Journal:  AAPS PharmSciTech       Date:  2012-03-14       Impact factor: 3.246

2.  Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aid.

Authors:  Satishkumar P Jain; Dharmini C Mehta; Sejal P Shah; Pirthi Pal Singh; Purnima D Amin
Journal:  AAPS PharmSciTech       Date:  2010-05-25       Impact factor: 3.246

3.  A novel preformulation tool to group microcrystalline celluloses using artificial neural network and data clustering.

Authors:  Josephine L P Soh; Fei Chen; Celine V Liew; Daming Shi; Paul W S Heng
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 4.  Raman characterization and chemical imaging of biocolloidal self-assemblies, drug delivery systems, and pulmonary inhalation aerosols: a review.

Authors:  Heidi M Mansour; Anthony J Hickey
Journal:  AAPS PharmSciTech       Date:  2007-11-30       Impact factor: 3.246

5.  Continuous Single-Step Wet Granulation with Integrated in-Barrel-Drying.

Authors:  Adrian Schmidt; Hans de Waard; Peter Kleinebudde; Markus Krumme
Journal:  Pharm Res       Date:  2018-06-25       Impact factor: 4.200

6.  Optimization of hot melt extrusion parameters for sphericity and hardness of polymeric face-cut pellets.

Authors:  Abdullah S Alshetaili; Bjad K Almutairy; Saad M Alshahrani; Eman A Ashour; Roshan V Tiwari; Sultan M Alshehri; Xin Feng; Bader B Alsulays; Soumyajit Majumdar; Nigel Langley; Karl Kolter; Andreas Gryczke; Scott T Martin; Michael A Repka
Journal:  Drug Dev Ind Pharm       Date:  2016-05-04       Impact factor: 3.225

7.  Ilex paraguariensis Pellets from a Spray-Dried Extract: Development, Characterization, and Stability.

Authors:  Francini K J Yatsu; Greice S Borghetti; Fagner Magalhães; Humberto G Ferraz; Eloir Paulo Schenkel; Valquiria L Bassani
Journal:  AAPS PharmSciTech       Date:  2015-07-11       Impact factor: 3.246

8.  Evaluation of ethylcellulose and its pseudolatex (Surelease) in preparation of matrix pellets of theophylline using extrusion-spheronization.

Authors:  Hadi Afrasiabi Garekani; Roshanak Dolatabadi; Abbas Akhgari; Mohammad Reza Abbaspour; Fatemeh Sadeghi
Journal:  Iran J Basic Med Sci       Date:  2017-01       Impact factor: 2.699

9.  Production of Ibuprofen Pellets Containing High Amount of Rate Retarding Eudragit RL Using PEG400 and Investigation of Their Physicomechanical Properties.

Authors:  Fatemeh Sadeghi; Hasan Hijazi; Hadi Afrasiabi Garekani
Journal:  Iran J Basic Med Sci       Date:  2011-07       Impact factor: 2.699

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.